Tag: world

Categories
World News

Biden is securing America’s place in world with infrastructure plan

Biden is securing America's place in world with infrastructure plan

It’s hard to overstate how bold President Joe Biden’s first 100 days in office, which will take place on April 30th, are. Behind this is the president’s desire to recharge America and at the same time improve the US’s chances in its escalating competition with China.

Biden’s audacity can best be measured by the numbers: the $ 4 trillion and count he took to fund an American pandemic surge, a surge in jobs and growth in the United States, and a mountain of national infrastructure investments (generous definition of “Infrastructure”) wants to generate. .

Never in my memory has a US president linked domestic investment so closely to US global standing – and now he is acting on that belief.

Biden made sure no one missed the connection to China when he unveiled his infrastructure spending proposal this week, which he described as “the largest single investment in American jobs since World War II.”

Biden asked, “Do you think China is waiting to invest in this digital infrastructure or research and development? I promise you they won’t wait. But they are counting on American democracy to be too slow, too limited and too divided is To keep up … We have to show the world. Much more important is that we show ourselves that democracy works. That we can come together on the big things. It’s the United States of America, for God’s sake! “

Veterans of the Obama years, Biden government officials say they act in several lessons: don’t let cable television’s criticism of your plans distract you, don’t let economists throw you off, don’t expect bipartisan support. and don’t set your sites too low.

“Go big or go home,” a former Obama official told me, summarizing the attitude that drove Biden’s first 100 days. This was made easier because the Democrats continued to control the House, de facto holding the Senate with a 50:50 split – and, if necessary, with a groundbreaking vote by the Vice President.

President Biden showed for the first time how ready he was to go through the US $ 1.9 trillion bailout plan passed in early March, one of the largest stimulus packages Americans had ever seen. It was far more than Republicans or many economists deemed necessary, but Biden had the votes.

Then this week he released plans for $ 2.3 trillion in infrastructure spending. Define this term to include everything from bridges and broadband networks to spending on the elderly and education for the young. As with the first bill, expect this to be largely party-political.

The mistake many of Biden’s critics make is focusing on the staggering numbers – rather than the staggering politics.

Think of all of those trillions less than a shipload of money than Biden’s down payment to secure America’s place in the world, place in history, and re-election of his party. In the short term, that means enough Americans will see results to ensure the 2022 mid-term elections.

In that sense, what appears to fiscal conservatives to be a reckless economy seems like prudent policy for the Biden team.

In some ways, President Biden uses his luck. Although Biden has suffered a great deal of misfortune in his personal and political life, the stars have been targeted since his election.

Covid’s rebound this year has been inevitable, but his government’s disciplined management of vaccine distribution has accelerated the process and his political standing. Biden last week moved the deadline to April 19 for all adults eligible for the COVID vaccine.

An economic recovery this year was also inevitable, but the Biden government’s stimulus measures should lead to growth of 6.4% this year, the highest since 1984, and then 3.5% in 2022, according to IMF projections.

It remains to be seen how much economic and political momentum $ 4 trillion can buy, with more to come. However, JP Morgan’s Jamie Dimon believes vaccines and deficit spending could spark a U.S. economic boom that could last through 2023, beyond the mid-term election where the Biden team knows victory is critical to their bigger goals .

It’s also hard to say what impact this will have on China, but so far competition between Beijing and Washington has intensified in the first few weeks of the Biden administration.

International visitors to China in recent years have seen a growing confidence among Chinese leaders in the inevitability of America’s decline and rise.

Many Chinese actions at home and abroad – bullying international partners, expanding the islands in the South China Sea, reversing Hong Kong’s democratic freedoms, and increasing threats to Taiwan – reflect confidence that they can act with relative impunity at a modest cost.

China is also betting that many of America’s most valuable allies and partners – Japan, South Korea, Germany and the European Union as a whole – have China as their number one trading partner and are reluctant to join a common cause against Beijing.

The bitter exchange at the first face-to-face meeting of Chinese and American heads of state and government in Alaska underscored how difficult it will be to have an increasingly militant relationship.

Perhaps the most compelling reason for President Biden to combine his domestic and international goals is that he is more likely to find political consensus on the need to confront China than he will find on any of his own spending plans.

Before Kurt Campbell joined the Biden government as Indo-Pacific coordinator, he wrote with Rush Doshi, who is now China director on the National Security Council, that the Chinese challenge could be a blessing to induce the US to make the appropriate investments in any case prudent.

“The path away from decline … could lead through a rare area prone to bipartisan consensus,” they wrote, “the need for the United States to face the China challenge.”

Frederick Kempe is a best-selling author, award-winning journalist, and President and CEO of the Atlantic Council, one of America’s most influential think tanks on global affairs. He worked for the Wall Street Journal for more than 25 years as foreign correspondent, assistant editor-in-chief and senior editor for the European edition of the newspaper. His latest book – “Berlin 1961: Kennedy, Khrushchev, and the Most Dangerous Place in the World” – was a New York Times bestseller and has been published in more than a dozen languages. Follow him on Twitter @FredKempe and subscribe here to Inflection Points, his view every Saturday of the top stories and trends of the past week.

More information from CNBC staff can be found here @ CNBCopinion on twitter.

Categories
Health

Kati Kariko Helped Defend the World From the Coronavirus

Kati Kariko Helped Shield the World From the Coronavirus

She grew up in Hungary, daughter of a butcher. She decided she wanted to be a scientist, although she had never met one. She moved to the United States in her 20s, but for decades never found a permanent position, instead clinging to the fringes of academia.

Now Katalin Kariko, 66, known to colleagues as Kati, has emerged as one of the heroes of Covid-19 vaccine development. Her work, with her close collaborator, Dr. Drew Weissman of the University of Pennsylvania, laid the foundation for the stunningly successful vaccines made by Pfizer-BioNTech and Moderna.

For her entire career, Dr. Kariko has focused on messenger RNA, or mRNA — the genetic script that carries DNA instructions to each cell’s protein-making machinery. She was convinced mRNA could be used to instruct cells to make their own medicines, including vaccines.

But for many years her career at the University of Pennsylvania was fragile. She migrated from lab to lab, relying on one senior scientist after another to take her in. She never made more than $60,000 a year.

By all accounts intense and single-minded, Dr. Kariko lives for “the bench” — the spot in the lab where she works. She cares little for fame. “The bench is there, the science is good,” she shrugged in a recent interview. “Who cares?”

Dr. Anthony Fauci, director of the National Institutes of Allergy and infectious Diseases, knows Dr. Kariko’s work. “She was, in a positive sense, kind of obsessed with the concept of messenger RNA,” he said.

Dr. Kariko’s struggles to stay afloat in academia have a familiar ring to scientists. She needed grants to pursue ideas that seemed wild and fanciful. She did not get them, even as more mundane research was rewarded.

“When your idea is against the conventional wisdom that makes sense to the star chamber, it is very hard to break out,” said Dr. David Langer, a neurosurgeon who has worked with Dr. Kariko.

Dr. Kariko’s ideas about mRNA were definitely unorthodox. Increasingly, they also seem to have been prescient.

“It’s going to be transforming,” Dr. Fauci said of mRNA research. “It is already transforming for Covid-19, but also for other vaccines. H.I.V. — people in the field are already excited. Influenza, malaria.”

For Dr. Kariko, most every day was a day in the lab. “You are not going to work — you are going to have fun,” her husband, Bela Francia, manager of an apartment complex, used to tell her as she dashed back to the office on evenings and weekends. He once calculated that her endless workdays meant she was earning about a dollar an hour.

For many scientists, a new discovery is followed by a plan to make money, to form a company and get a patent. But not for Dr. Kariko. “That’s the furthest thing from Kate’s mind,” Dr. Langer said.

She grew up in the small Hungarian town of Kisujszallas. She earned a Ph.D. at the University of Szeged and worked as a postdoctoral fellow at its Biological Research Center.

In 1985, when the university’s research program ran out of money, Dr. Kariko, her husband, and 2-year-old daughter, Susan, moved to Philadelphia for a job as a postdoctoral student at Temple University. Because the Hungarian government only allowed them to take $100 out of the country, she and her husband sewed £900 (roughly $1,246 today) into Susan’s teddy bear. (Susan grew up to be a two-time Olympic gold medal winner in rowing.)

When Dr. Kariko started, it was early days in the mRNA field. Even the most basic tasks were difficult, if not impossible. How do you make RNA molecules in a lab? How do you get mRNA into cells of the body?

In 1989, she landed a job with Dr. Elliot Barnathan, then a cardiologist at the University of Pennsylvania. It was a low-level position, research assistant professor, and never meant to lead to a permanent tenured position. She was supposed to be supported by grant money, but none came in.

She and Dr. Barnathan planned to insert mRNA into cells, inducing them to make new proteins. In one of the first experiments, they hoped to use the strategy to instruct cells to make a protein called the urokinase receptor. If the experiment worked, they would detect the new protein with a radioactive molecule that would be drawn to the receptor.

“Most people laughed at us,” Dr. Barnathan said.

One fateful day, the two scientists hovered over a dot-matrix printer in a narrow room at the end of a long hall. A gamma counter, needed to track the radioactive molecule, was attached to a printer. It began to spew data.

Their detector had found new proteins produced by cells that were never supposed to make them — suggesting that mRNA could be used to direct any cell to make any protein, at will.

“I felt like a god,” Dr. Kariko recalled.

She and Dr. Barnathan were on fire with ideas. Maybe they could use mRNA to improve blood vessels for heart bypass surgery. Perhaps they could even use the procedure to extend the life span of human cells.

Dr. Barnathan, though, soon left the university, accepting a position at a biotech firm, and Dr. Kariko was left without a lab or financial support. She could stay at Penn only if she found another lab to take her on. “They expected I would quit,” she said.

Universities only support low-level Ph.D.s for a limited amount of time, Dr. Langer said: “If they don’t get a grant, they will let them go.” Dr. Kariko “was not a great grant writer,” and at that point “mRNA was more of an idea,” he said.

But Dr. Langer knew Dr. Kariko from his days as a medical resident, when he had worked in Dr. Barnathan’s lab. Dr. Langer urged the head of the neurosurgery department to give Dr. Kariko’s research a chance. “He saved me,” she said.

Updated 

April 10, 2021, 6:01 p.m. ET

Dr. Langer thinks it was Dr. Kariko who saved him — from the kind of thinking that dooms so many scientists.

Working with her, he realized that one key to real scientific understanding is to design experiments that always tell you something, even if it is something you don’t want to hear. The crucial data often come from the control, he learned — the part of the experiment that involves a dummy substance for comparison.

“There’s a tendency when scientists are looking at data to try to validate their own idea,” Dr. Langer said. “The best scientists try to prove themselves wrong. Kate’s genius was a willingness to accept failure and keep trying, and her ability to answer questions people were not smart enough to ask.”

Dr. Langer hoped to use mRNA to treat patients who developed blood clots following brain surgery, often resulting in strokes. His idea was to get cells in blood vessels to make nitric oxide, a substance that dilates blood vessels, but has a half-life of milliseconds. Doctors can’t just inject patients with it.

He and Dr. Kariko tried their mRNA on isolated blood vessels used to study strokes. It failed. They trudged through snow in Buffalo, N.Y., to try it in a laboratory with rabbits prone to strokes. Failure again.

And then Dr. Langer left the university, and the department chairman said he was leaving as well. Dr. Kariko again was without a lab and without funds for research.

A meeting at a photocopying machine changed that. Dr. Weissman happened by, and she struck up a conversation. “I said, ‘I am an RNA scientist — I can make anything with mRNA,’” Dr. Kariko recalled.

Dr. Weissman told her he wanted to make a vaccine against H.I.V. “I said, ‘Yeah, yeah, I can do it,’” Dr. Kariko said.

Despite her bravado, her research on mRNA had stalled. She could make mRNA molecules that instructed cells in petri dishes to make the protein of her choice. But the mRNA did not work in living mice.

“Nobody knew why,” Dr. Weissman said. “All we knew was that the mice got sick. Their fur got ruffled, they hunched up, they stopped eating, they stopped running.”

It turned out that the immune system recognizes invading microbes by detecting their mRNA and responding with inflammation. The scientists’ mRNA injections looked to the immune system like an invasion of pathogens.

But with that answer came another puzzle. Every cell in every person’s body makes mRNA, and the immune system turns a blind eye. “Why is the mRNA I made different?” Dr. Kariko wondered.

A control in an experiment finally provided a clue. Dr. Kariko and Dr. Weissman noticed their mRNA caused an immune overreaction. But the control molecules, another form of RNA in the human body — so-called transfer RNA, or tRNA — did not.

A molecule called pseudouridine in tRNA allowed it to evade the immune response. As it turned out, naturally occurring human mRNA also contains the molecule.

Added to the mRNA made by Dr. Kariko and Dr. Weissman, the molecule did the same — and also made the mRNA much more powerful, directing the synthesis of 10 times as much protein in each cell.

The idea that adding pseudouridine to mRNA protected it from the body’s immune system was a basic scientific discovery with a wide range of thrilling applications. It meant that mRNA could be used to alter the functions of cells without prompting an immune system attack.

“We both started writing grants,” Dr. Weissman said. “We didn’t get most of them. People were not interested in mRNA. The people who reviewed the grants said mRNA will not be a good therapeutic, so don’t bother.’”

Leading scientific journals rejected their work. When the research finally was published, in Immunity, it got little attention.

Dr. Weissman and Dr. Kariko then showed they could induce an animal — a monkey — to make a protein they had selected. In this case, they injected monkeys with mRNA for erythropoietin, a protein that stimulates the body to make red blood cells. The animals’ red blood cell counts soared.

The scientists thought the same method could be used to prompt the body to make any protein drug, like insulin or other hormones or some of the new diabetes drugs. Crucially, mRNA also could be used to make vaccines unlike any seen before.

Instead of injecting a piece of a virus into the body, doctors could inject mRNA that would instruct cells to briefly make that part of the virus.

“We talked to pharmaceutical companies and venture capitalists. No one cared,” Dr. Weissman said. “We were screaming a lot, but no one would listen.”

Eventually, though, two biotech companies took notice of the work: Moderna, in the United States, and BioNTech, in Germany. Pfizer partnered with BioNTech, and the two now help fund Dr. Weissman’s lab.

Soon clinical trials of an mRNA flu vaccine were underway, and there were efforts to build new vaccines against cytomegalovirus and the Zika virus, among others. Then came the coronavirus.

Researchers had known for 20 years that the crucial feature of any coronavirus is the spike protein sitting on its surface, which allows the virus to inject itself into human cells. It was a fat target for an mRNA vaccine.

Chinese scientists posted the genetic sequence of the virus ravaging Wuhan in January 2020, and researchers everywhere went to work. BioNTech designed its mRNA vaccine in hours; Moderna designed its in two days.

The idea for both vaccines was to introduce mRNA into the body that would briefly instruct human cells to produce the coronavirus’s spike protein. The immune system would see the protein, recognize it as alien, and learn to attack the coronavirus if it ever appeared in the body.

The vaccines, though, needed a lipid bubble to encase the mRNA and carry it to the cells that it would enter. The vehicle came quickly, based on 25 years of work by multiple scientists, including Pieter Cullis of the University of British Columbia.

Scientists also needed to isolate the virus’s spike protein from the bounty of genetic data provided by Chinese researchers. Dr. Barney Graham, of the National Institutes of Health, and Jason McClellan, of the University of Texas at Austin, solved that problem in short order.

Testing the quickly designed vaccines required a monumental effort by companies and the National Institutes of Health. But Dr. Kariko had no doubts.

On Nov. 8, the first results of the Pfizer-BioNTech study came in, showing that the mRNA vaccine offered powerful immunity to the new virus. Dr. Kariko turned to her husband. “Oh, it works,” she said. “I thought so.”

To celebrate, she ate an entire box of Goobers chocolate-covered peanuts. By herself.

Dr. Weissman celebrated with his family, ordering takeout dinner from an Italian restaurant, “with wine,” he said. Deep down, he was awed.

“My dream was always that we develop something in the lab that helps people,” Dr. Weissman said. “I’ve satisfied my life’s dream.”

Dr. Kariko and Dr. Weissman were vaccinated on Dec. 18 at the University of Pennsylvania. Their inoculations turned into a press event, and as the cameras flashed, she began to feel uncharacteristically overwhelmed.

A senior administrator told the doctors and nurses rolling up their sleeves for shots that the scientists whose research made the vaccine possible were present, and they all clapped. Dr. Kariko wept.

Things could have gone so differently, for the scientists and for the world, Dr. Langer said. “There are probably many people like her who failed,” he said.

Categories
Business

Out of Trump’s Shadow, World Financial institution President Embraces Local weather Combat

Out of Trump’s Shadow, World Bank President Embraces Climate Fight

Mr. Malpass ingratiated himself with the employees of the World Bank with his steady, reserved approach and his personable manner. He has also benefited from low expectations. But some development experts still want to see more of his tenure with three more years.

Scott Morris, a senior fellow at the Center for Global Development, a think tank in Washington, said it was unfortunate that the World Bank seemed to leave the door open to funding fossil fuel projects. He suggested that Mr. Malpass did not have to come up with a clear strategic vision for the bank just yet, but attributed acceptance of climate change to him.

“It is remarkable to compare his statements today with his positions as a tax officer in the Trump administration two years ago, when the official position was to remove the word ‘climate’ from documents of a multilateral institution,” said Morris. “According to this standard, he has made a remarkable development into a climate leader.”

He added, “But it’s a question versus what, and is he up to the job of running this critical body on climate finance?”

The bank will accelerate its efforts in the coming months. Mr Malpass, in a speech last month about building a green, resilient and inclusive recovery. said His team integrated climate into all of the bank’s country strategies and would produce climate and development reports for 25 countries this year.

Mr. Malpass has recently worked to gain favor with the Biden administration. He speaks regularly to Ms. Yellen and personally invited her to take part in last week’s climate discussion.

When asked what the transition from the Trump administration to the Biden administration had meant for the bank, Mr. Malpass responded carefully. He noted that under Mr. Trump, the United States had approved a capital increase for the bank. He said the new White House team is deeply committed to the bank’s goals of reducing poverty, making food accessible and preparing countries for a changing climate.

“The guidelines of the Biden administration were very supportive of this mission,” said Malpass.

Lisa Friedman contributed to the coverage.

Categories
Business

How a lot it prices to journey the world full time on a yacht

How much it costs to travel the world full time on a yacht

The Sueiros had it all – great careers, a community of friends and children enrolled in a top international school in Boston.

Will was a chartered accountant and Jessica ran a graphic design business from home. Life was “comfortable, uneventful, and routine,” said Jessica Sueiro.

“Life was good” for the Sueiro family before they traveled the world full time, but they wanted adventure and a worldwide education for their children, said Jessica Sueiro.

Courtesy Jessica Sueiro

However, they were over-budgeted and spent around $ 10,000 a month on their finances – not on a “pampered life” with fancy cars or weekend ski trips, Sueiro said, but on rent, private schooling and an “image” that is presentable had to be clothes and regular haircuts.

“We had the lifestyle we dreamed of,” said Sueiro. “But when we got it, we weren’t sure it was the way to go for our family.”

A “leap into the unknown”

The family went on a “summer test trip” to Paris to see if they could survive in a foreign country, Sueiro said.

“We not only survived, we also thrived,” she told CNBC. “We lived a lot less and were so happy.”

With two children, ages 6 and 10, the Sueiros sold 85% of their belongings, took out international health insurance, opted for paperless bills, and left Boston in 2014 “jumping into the unknown,” she said.

Since then, the family has visited more than 65 countries and members have traveled to all seven continents, Sueiro said.

The Sueiro family has lived in surf hostels, yurts, tree houses, pod hotels, boats, an RV and now a catamaran, Jessica Sueiro said.

Courtesy Roam Generation

For the first three years, the Sueiros lived in places for nine to twelve months, rented furnished houses, and traveled extensively, Sueiro said. The family lived in a 21-foot RV for the next 2 1/2 years, constantly moving and visiting every country in Europe as well as Morocco.

They had just arrived in Japan when the pandemic broke out. They eventually returned to France, where they have an extended stay visa, and bought a 38-foot catamaran that they have been living in since August 2020.

Yacht life for $ 2,500 a month

The Sueiros had very little sailing experience when they bought their boat, which makes traveling over water more difficult than over land – at least for now, Sueiro said.

She said she believes that “sailing will eventually become a much easier and cheaper way to travel,” despite boats “having a reputation for costing a fortune”.

“Our monthly budget since we’ve been full-time travelers has always been $ 2,500 a month,” said Sueiro, who includes health insurance but not school or business expenses. “Right now … we’re a little bit lower than that.”

There have been allegations that our children are not properly educated, that we must have family allowances, that we are lost souls.

After the initial cost of buying and equipping the boat, the bills “balanced out” and the family’s biggest recurring expenses are grocery, school, health and boat insurance, SIM cards and regular boat repairs, she said. The general rule, she added, is to allow 10% -30% of the boat purchase price for annual repairs and upgrades.

“There are many assumptions about this type of lifestyle … the number one by far is that you have to be rich,” said Sueiro. “I can’t speak for others, but I can tell you that we work a lot … we are also very economical.”

Jessica and her husband worked remotely for the first three years before starting WorldTowning, a travel coaching company for long-term travelers. Her group tours are starting again this fall and are almost sold out, she said.

The needs of a nomadic lifestyle

Items (including computers) valued at USD 10,000 were stolen from the Sueiros in Belgium. They were abused in Norway and are stuck in a rainy gorge in Turkey – at night.

“Our biggest ongoing difficulty, however, is judging how we live,” Sueiro said, adding that this has come from educators, potential employers, doctors and business customers.

“There have also been allegations that our children are not properly educated, that we have to have family allowances, that we are lost souls, irresponsible and much more,” she said.

Largo Sueiro attended a private school in Costa Rica and Ecuador.

Courtesy Roam Generation

The children have attended private and public schools and have been homeschooled (“or as we call it the world school”). Both want to go to university in the United States and the oldest, Avalon, 16, is preparing to take courses at online universities, Sueiro said.

“Will and I have adopted the philosophy that no one can vote on how we live our lives,” she said, adding that the current shift to remote work is softening attitudes towards alternative lifestyles.

Inspired by a movie

The Careys were a “normal family” who lived in a three bedroom house in Adelaide, Australia – until they were inspired to travel the world after watching a documentary about Laura Dekker, the youngest person to be alone Circled globe.

The couple saved more than two years, took sailing courses and bought a 47-foot boat “unseen” in Grenada, an island nation in the Caribbean.

The Careys worked for the Australian government, had a mortgage and credit card debt before sailing around the world, Erin Carey said.

Courtesy Roam Generation

“We basically jumped on board and did everything our own way,” said Erin with a laugh. “We ran aground, our engine failed … we had to be towed.”

Despite being “non-seafarers,” the couple and their three young sons sailed the Caribbean before crossing the Atlantic 18 months later, she said.

The family returned to their home in Australia at the beginning of the pandemic, but quickly realized that country life was not for them. The family was always “rushing” to school and sports activities, and the kids read less and stayed indoors more, Carey said.

We are a family of five and we spend probably around $ 4,000 a month.

“We didn’t spend time as a family,” she said. “There were very few moments at home when we really felt alive.”

The Careys sold their house and returned to their boat in the Azores this March.

The pros and cons of boating life

Despite the freedom and adventure, Carey said it was normal to get tired of the lifestyle because “it’s super hard to live on a boat”.

Cramped living spaces, blocked toilets, and no hot showers or cars (“we have to take our groceries everywhere”) are just the beginning. “Rolly anchorages”, a boat term for a rocking boat, prevent a good sleep.

But the days are not rushed. The kids take classes for two hours each morning through Acellus, an online school, while Carey runs a PR agency called Roam Generation from her yacht. Then the family can go on a hike or a museum, or the children can play or fish with other children in the marina. You have started reading again, she said.

“Kids on boats are really exceptional for some reason,” said Carey, who uses a private Facebook group called Kids4Sail to connect with other boat families.

Courtesy Roam Generation

Are children rare in the church? Not at all, said Carey.

The “cruise” community is well connected, and families with “boat children” visit each other.

“Often times, people change their plans and go where the kids’ boats are because happy kids make this lifestyle so much better,” Carey said.

Cruise: Not just for the ultra-rich

To finance life on a boat full time, some people save money to sail for a period of time while others sell or rent their houses. Others operate location-independent businesses from their boats. Many are retired.

“We’re a family of five and we spend probably about $ 4,000 a month,” she said. “There are people who do it for literally $ 500 a month and then obviously there are people who live on super yachts.”

Carey, whose family eats out several times a week and occasionally rents a car, believes what they spend is “pretty average” for cruise families.

Courtesy Roam Generation

With no mortgage or car, Carey said, “Life on the boat is cheaper than life in our home.” “Things on boats break all the time … so you have to be prepared.”

“Your sails are tearing, it’s going to be $ 5,000,” she said. “They say boot stands for ‘Bring Out Another Thousand’.”

Carey said while cruises were “much more difficult” in the Covid era, boat sales were “through the roof”. While the coronavirus caused some to return home, it spurred many others to start a lifestyle on board.

Carey is researching going to the Mediterranean next and then sailing back to the Caribbean around Christmas.

Cruisers (Halloween is celebrated here in Grenada) are mostly well-educated and motivated people, but “issues like wealth, social status or employment rarely come up,” said Carey.

Courtesy Roam Generation

“I think that’s the beauty of boating, it’s so unknown,” she said. “I really like that I literally have no idea where we’ll be in three months.”

Carey said that while boating is tough, “you just have to be really determined and persistent to find a way to make it work.”

Categories
Business

Jim Cramer says Walmart is among the many shares that can do properly in a ‘hybrid world’

Jim Cramer says Walmart is among the stocks that will do well in a 'hybrid world'

CNBC’s Jim Cramer on Wednesday announced a handful of stocks that he believes will do well in the emerging “hybrid world”.

The Mad Money host anticipates many people will follow some pandemic routines as Covid-19 health constraints ease and more offices reopen in the coming months. For this reason, Cramer recommended that investors get involved in the hybrid economy.

“We’re moving into a hybrid world where the staying-at-home habits are persistent, but you also have opportunities to go out and do things,” he said. “You have to stick with the stocks that win one way or the other.”

Cramer pointed out the following stock picks as hybrid games:

All but two of Cramer’s picks have posted double-digit gains this year, outperforming the broader market. Williams-Sonoma is the group’s biggest winner, up more than 75%. Walmart and McCormick are down 3% and nearly 7%, respectively, in 2021.

Cramer’s recommendations came after the S&P 500 hit a record close on Wednesday.

Disclosure: Cramer’s charitable foundation owns shares in Walmart.

Disclaimer of liability

Questions for Cramer?
Call Cramer at 1-800-743-CNBC

Would you like to dive deep into Cramer’s world? Open it up!
Mad Money Twitter – Jim Cramer Twitter – Facebook – Instagram

Questions, comments, suggestions for the Mad Money website? madcap@cnbc.com

Categories
Health

World Leaders Name for an Worldwide Treaty to Fight Future Pandemics

World Leaders Call for an International Treaty to Combat Future Pandemics

BRUSSELS – Citing what they call “the greatest challenge facing the global community since the 1940s,” the leaders of more than two dozen countries, the European Union and the World Health Organization signed an international treaty on Tuesday to protect the world World closed before pandemics.

In a joint article published in numerous newspapers around the world, leaders warn that the current coronavirus pandemic will inevitably be followed by others at some point. You outline a treaty that is intended to enable universal and equitable access to vaccines, drugs and diagnostics. This proposal was first made in November by Charles Michel, President of the European Council, the body that represents the heads of state and government of EU countries.

The article argues that an international understanding similar to that after World War II that led to the United Nations is required to build cross-border collaboration before the next global health crisis stirs economies and lives. The current pandemic is “a strong and painful reminder that no one is safe until everyone is safe,” write the leaders.

The proposed treaty is a recognition that the current system of international health institutions, symbolized by the relatively powerless World Health Organization, a United Nations agency, is inadequate to deal with the problem.

“There will be other pandemics and other major health emergencies. No single government or multilateral agency can counter this threat alone, ”state the heads of state and government. “We believe that nations should work together to develop a new international treaty for preparing for and responding to pandemics.”

The treaty would call for better warning systems, data sharing, research, and the manufacture and distribution of vaccines, medicines, diagnostics and personal protective equipment.

“At a time when Covid-19 has taken advantage of our weaknesses and divisions, we must seize this opportunity and unite as a global community for peaceful cooperation that goes beyond this crisis,” write the heads of state and government. “Building our capacities and systems to achieve this will take time and will require sustained political, financial and social commitment over many years.”

However, the article is not clear about what would happen if a country chooses not to cooperate fully or to delay exchanges of scientific information, as China has been accused of cooperating with WHO

At least so far, China has not signed the letter. Neither does the United States.

At a press conference in Geneva on Tuesday, the Director General of the World Health Organization, Tedros Adhanom Ghebreyesus, said that “all member states will be represented” at the start of the treaty discussions.

When asked if the leaders of China, the United States and Russia had been asked to sign the letter, he said that some leaders had decided to sign up.

“The comments from member states, including the US and China, have actually been positive,” he said. “The next steps will be to involve all countries and that is normal,” he added. “I don’t want it to be seen as a problem.”

In addition to European countries and the WHO, nations in Africa, Asia and Latin America were also among those who signed the letter.

Categories
World News

World leaders name for extra cooperation

World leaders call for more cooperation

A staff member checks information about a woman who has just finished quarantine at a quarantine center on March 16, 2020 in Shanghai, China.

China News Service | China News Service | Getty Images

World leaders on Tuesday jointly called for a pandemic treaty, arguing that the Covid-19 crisis represented the “greatest challenge facing the global community since the late 1940s”.

The joint letter, published in newspapers around the world, was signed by more than 20 global leaders and representatives from Europe, Africa, South Africa and Asia, including British Prime Minister Boris Johnson, French President Emmanuel Macron and German Chancellor Angela Merkel.

“Today, as we are together in the fight against the Covid-19 pandemic, we are equally united in the hope that we can build a more robust international health architecture that provides better protection for future generations,” the signatories said.

“There will also be pandemics and other major health crises in the future. No national government or multilateral organization can face such a threat alone. It is only a matter of when the time comes.”

The Director General of the World Health Organization, Tedros Adhanom Ghebreyesus, as well as the President of the European Council, Charles Michel, one of the first officials to call for an international agreement to combat future pandemics, also signed the letter.

They will make one more comment on a possible contract at a WHO press conference Tuesday morning before WHO awaits its joint investigation with China into the causes of the Covid-19 pandemic, which is widely expected to deliver the first results recently presented repeated month.

In February, the WHO and China team of experts reported that the coronavirus “most likely” came from animals before it spread to humans, rejecting the theory that the disease had leaked from a laboratory in the Chinese city of Wuhan.

However, there were unanswered questions about whether the team was able to fully investigate the matter in the face of delays in the investigation (the WHO-led team of experts traveled to China in early 2021, more than a year after the pandemic first emerged) and China’s acute sensitivity to the pandemic.

Beijing has denied allegations of withholding information and was slow to warn global health officials of the new coronavirus when it emerged and vehemently denied that it was responsible for the initial outbreak that severely damaged and nearly killed the global economy so far 2 , 8 million people.

According to a draft copy received from The Associated Press, the conclusion of the joint WHO-China study, due to be released later Tuesday, will reiterate initial findings that the virus was most likely from animals and suggest further research on each scenario – except for the laboratory leak hypothesis.

Need for more transparency

Transparency, or a lack of it, has been a persistent flaw throughout the coronavirus pandemic, a global health crisis for which few governments seemed prepared. The UK has already announced that it will set up a new health security agency to ensure the country is prepared for future pandemics. The lack of international coordination during the pandemic also appears grave, with vaccine delivery and distribution being the most recent source of sharpness between countries, particularly between the EU and the UK

International leaders now calling for an international pandemic treaty say the deal’s main objective is “to promote a nationwide and societal approach that strengthens national, regional and global capacities and resilience to future pandemics”.

The proposed system would provide for increased international cooperation to improve alert systems, data and research sharing, and “local, regional and global development and distribution of medical and public health measures such as vaccines” . Medicines, diagnostics and personal protective equipment. “

Perhaps just as importantly, the treaty would aim to promote “more transparency, cooperation and accountability” among the signatories, the heads of state and government hope.

“Such a treaty would lead to more mutual accountability and responsibility, transparency and cooperation in the international system according to its rules and norms,” ​​they said.

“To achieve this, we will work with world leaders and all stakeholders, including civil society and the private sector. We believe that, as leaders and leaders of international institutions, we have a responsibility to ensure that the World is learning the lessons of the Covid-19 pandemic. “

The Industrialized Nations Group of Seven (G-7) is expected to further investigate the idea of ​​the pandemic treaty at a summit in Cornwall, UK in June.

Categories
Business

Do not wager on the top of the world

Don't bet on the end of the world

Jim Cramer on “Mad Money”.

Scott Mlyn | CNBC

A year ago, on Tuesday, the S&P 500 suffered its worst one-day decline in more than three decades amid a severe week-long decline sparked by the global coronavirus pandemic.

CNBC’s Jim Cramer said stocks have more than rebounded from a rapid decline fueled by historic government interventions that helped avert an even worse crisis.

“If there’s just one thing you can learn from the pandemic … I want you to remind yourself that betting at the end of the world is a sucker game,” said the Mad Money host. “The next time you think the world is going to end, you have to assume that it isn’t. I want you to take the other side of the deal. I want you to bet against the end of the world.”

The key averages bottomed out about a week after the March 16, 2020 meeting.

Since its lowest point last year, the Nasdaq Composite has more than doubled since trading closed on Tuesday of 13,471.57. The S&P 500 and Dow Jones Industrial Average both rebounded more than 80% to 3,962.71 and 32,825.95, respectively.

Cramer accused Washington lawmakers and officials of helping to turn the market after thousands of business closings and the loss of millions of jobs.

“If our policy makers are really learning from the past and our scientists are doing their magic, then the darkest moment is really just before daybreak and the light at the end of the tunnel is real sun, not that of an oncoming train,” said Cramer.

Categories
Entertainment

A Rift Over Artwork and Activism Ripples By way of the Efficiency World

A Rift Over Art and Activism Ripples Through the Performance World

Jedediah Wheeler, Executive Director of Peak Performances at Montclair State University in New Jersey, introduced choreographer Emily Johnson at a conference of the performing arts presenters in January 2020. Wheeler called himself “the happiest person in the room” to give her the job.

Johnson, 44, an indigenous artist of Yup’ik descent, is known for performances based on her heritage, ceremonies that could last all night under the stars, gatherings in search of healing and social change.

Wheeler, 71, founded Peak Performances in 2004 and made the state of Montclair an unlikely home for the avant-garde. The series attracted attention by producing and showcasing works by artists such as Robert Wilson and Italian provocateur Romeo Castellucci before reaching New York City.

But Johnson didn’t join that list. Not long after the conference, Johnson Wheeler asked in a telephone conversation about his “personal commitment to a decolonization process,” she later wrote. She suggested that Peak Performances begin land recognition by taking a series of steps to recognize the area’s original residents, build relationships with other indigenous artists, and engage First Nations students on campus, among other things. Wheeler said Peak Performances couldn’t set a policy because it was only a small part of a larger university, responded dismissively, and then when pressed, angry.

The dispute became open earlier this year when Johnson severed ties with Peak Performances and wrote about her decision in “A Letter I Hope Don’t Need To Be Written In The Future,” which she posted online on Jan. 22nd compared Wheeler’s behavior – what they termed his screaming, his failure to apologize, his use of power – to “white anger”. She referred to “colonial settler violence”, the murder of indigenous women, and rape. She said that Peak Performances was “an unsafe and unethical” place to work.

Wheeler said he was “shocked and hurt” by the letter. He admitted mistreating the situation, but “white anger?” he asked. “It’s so imprecise. Check out the artists I’ve supported. “

“What happened is that I made a mistake,” he added. “I didn’t really know what Emily was asking. I take full responsibility for not hearing them. “

Their break became a topic of conversation in the non-profit world of the performing arts, which led to expressions of solidarity, calls for reform and terminated contracts. The letter and responses to it show accelerated changes in the way people in the arts think and speak about the roles of artists and moderators, standards of behavior and power in the workplace, and how all of this relates to deep wounds in American history .

Johnson’s work isn’t just about performance. It has to do with their activism and advocacy for indigenous peoples, their commitment to slow community building processes and institutional reforms. It is inextricably linked to decolonization, a global political and cultural movement that has also been adopted by many universities and museums.

Decolonization initiatives can range from staff training and discussions to quotas, reparations, and land restitution. One aspect is the recognition of the land, an increasingly common practice of officially honoring the indigenous people of a place in lectures, ceremonies and in public.

Johnson’s letter presented her experience with Wheeler as symptomatic. She linked it with other recent calls for systemic change in dance and theater – calls in response to the pandemic, theater closings and protests against Black Lives Matter last summer.

In this broader, volatile context, her letter detonated. More than 100 nonprofit performing arts presenters, including some of the best known, have signed an online declaration of solidarity calling for “Accountability and repair not just for this case, but for our entire field”. And more than 1,000 artists have signed a similar call to action (“We’re All In”) with a long list of suggestions to address both Johnson’s experience and more general issues – contracts and funding – he raises.

The State of Montclair issued a statement in defense of Wheeler, stating that Peak Performances “is intentionally seeking out emerging artists, artists from underrepresented backgrounds, and artists whose work challenges established norms and practices”. It was found that as the head of “just one of many hundreds of units and programs” at the university, Wheeler was not authorized to endorse Johnson’s proposals. The university’s “robust” policy on social justice and diversity had been established at the institutional level.

“The university does not formulate or pass major policy decisions through a contract with a particular performing artist,” it said.

WNET All Arts, which broadcast the Peak Performances projects, cut ties with the university. The Wet Ink Ensemble, which had been working on an opera production with Peak Performances, has discontinued this collaboration. Other artists who wanted to work with Peak, including Bill T. Jones, made a statement about their intention to “influence change from within”.

What happened? In interviews, Johnson and Wheeler denied some facts, but the differences in their stories lie more in interpretation – what the other side meant, who should have understood what and when, what is acceptable and what is not.

Wheeler first became interested in Johnson in 2018 when she wrote an essay for the organization’s publication, the Peak Journal. “She asked a question that was profound and courageous to my ears,” he said. “Whose country did you steal?” (What she actually wrote was “Do you know whose country you are in?”)

“Could this force be captured in a performance?” he said he was wondering.

In October 2018, Wheeler offered Johnson a commission – possibly the largest of her career in terms of scope and fee. In January 2020, however, the contract was still being negotiated. One of the sticking points was the scope of the project outside of performance.

At a meeting of indigenous artists in January, Wheeler read Johnson’s contract rider calling on the moderators of her work to contact local indigenous leaders and bring the country’s appreciation to the general public. “I thought, ‘This is brave, but it won’t fly,'” he said. “‘Nobody’s going to sign this.'”

In the February phone call that caused the rift, Wheeler made his position “incredibly clear,” saying his department was unable to establish guidelines.

“My idea of ​​social justice is on the stage,” he said, adding that in a 2018 peak production, “Hatuey: Memory of Fire,” a country recognition was performed as part of the work. This is much more powerful than a preshow speech. “If Emily Johnson came up to me with her public letter and said, ‘This is the script,’ I would say, ‘Do it!'”

For Johnson, social engagement is no extra. “There is no separation between the process of dancing and the processes of decolonization,” she said in an interview.

“The US is based on the fact that you extract from indigenous peoples,” she added. “Jed wanted the effects of my work, but not the work.”

How Wheeler did his job was, in Johnson’s view, the crux of the problem. She said he shouted “I’ll call the shots” on the phone and gave her 24 hours to decide if the project was progressing on his terms. Then he hung up.

“I set the tone,” said Wheeler in an interview. Did he yell and hang up? “Sometimes I don’t hear what I’m saying the way others hear it,” he said. “That’s not unusual for me. I was frustrated with not seeing the limitations of my office and dropped the call. “

Talking about the call a year later still made Johnson shudder. At the time, she said, she wanted to say goodbye to any dealings with Wheeler – “this is exactly what white supremacy looks like,” she wrote in her public letter – but decided that “fighting anger was part of the decolonization work.”

The next day, she emailed Wheeler (quoted in her letter) stating that she did not have all of the answers on “What Decolonization Looks Like”, that it was a “living and creative process,” and that she according to “a commitment in good faith”, which is not necessarily specified in a contract.

Negotiations continued – between Wheeler’s employees and Johnson’s producers. For Johnson, Wheeler’s failure to acknowledge his behavior (he only responded after her public letter) meant further abuse.

Then came the pandemic, which created more complications and confusion. In late March, Peak Performances announced to Johnson that their project had been postponed. However, negotiations continued until Johnson ended the relationship in January.

Many former Peak employees responded in interviews to Johnson’s public letter that they had regularly seen and experienced similar behavior by Wheeler. Older employees saw him as a recognizable type: the bullying, briefly merged impresario, whose outbursts had to be accepted. For the younger, the behavior fits in with the characteristics of the so-called white supremacy work culture, as described in articles shared by their friends and colleagues recently.

“If I’ve hurt someone because I’ve criticized their job performance, I’m sorry,” said Wheeler. “I am learning how everyone likes to say.”

But the talks that Johnson’s letter provoked extend beyond Wheeler and Montclair State.

“Everyone in the field is talking about it,” said Colleen Jennings-Roggensack, executive director of Arizona State University Gammage, a presenting organization. “The situation was badly handled and Emily was wronged.”

“I’m an African American woman,” she added, “and I think this is an educational moment. It’s not the time to throw anyone under the bus – we don’t have enough buses, there would be too many bodies. But how do we see it face to face? How do artists, moderators and funders work together fairly? “

Johnson, for his part, continues her work in the broadest sense. At institutions like Jacob’s Pillow, the Santa Fe Opera, and the Field Museum, most of the processes she lists in her expanded “Decolonization Tab” are already running.

Johnson is also developing the project she did with Peak Performances called “Being Future Being”. It began, she said, before the pandemic, before her experience with Wheeler, as a vision of “embodying a better future for all of us,” work that would transform consciousness and commit people to a process of change. This work may already have started.

Categories
Health

Can the World Be taught From South Africa’s Vaccine Trials?

Can the World Learn From South Africa’s Vaccine Trials?

In a year that has fluctuated between staggering profits and brutal setbacks at Covid-19, few moments have been as sobering as last month’s discovery that a variant of coronavirus in South Africa was dampening the effects of one of the most effective vaccines in the world.

That finding – from a South African trial with the Oxford-AstraZeneca shot – revealed how quickly the virus had managed to evade human antibodies, ending what some researchers have described as the worldwide honeymoon period with Covid-19 vaccines, and continuing that Hopes return to contain the pandemic.

As countries prepare for this difficult turnaround, the story of how scientists uncovered the dangers of the variant in South Africa has brought focus to the global vaccine trials that were essential in warning the world.

“Historically, people might have thought that a problem in a country like South Africa would remain in South Africa,” said Mark Feinberg, executive director of IAVI, a nonprofit scientific research group. “But we’ve seen how quickly variants pop up all over the world. Even wealthy countries need to pay a lot of attention to the developing landscape around the world. “

After the deliberations in the vaccine race, these global studies saved the world from sleepwalking into the second year of the coronavirus without knowing how the pathogen might weaken the body’s immune response, scientists said. They also provide lessons on how vaccine manufacturers can combat new variants and eliminate long-standing health inequalities this year.

The deck is often stacked against drug trials in poorer countries: drug and vaccine manufacturers attract their largest commercial markets, and often avoid the cost and uncertainty of testing products in the global south. Less than 3 percent of clinical trials are conducted in Africa.

However, the emergence of new varieties in South Africa and Brazil has shown that vaccine manufacturers cannot afford to wait years, as they have often done, before testing that shots work in poorer ones for rich countries.

“If you fail to identify and respond to what is happening on a supposedly distant continent, it has a significant impact on global health,” said Clare Cutland, a vaccine scientist at the Witwatersrand University in Johannesburg who coordinated the Oxford study. “These results have shown the world that there isn’t a single pathogen sitting there doing nothing – it is constantly mutating.”

Although the Oxford vaccine offers minimal protection against mild or moderate cases caused by the variant in South Africa, it will likely prevent these patients from becoming seriously ill, preventing an increase in hospitalizations and deaths. Laboratory studies have produced a mix of hopeful and more worrying results about how much the variant disrupts Pfizer and Moderna’s recordings.

Even so, vaccine manufacturers are trying to test updated booster vaccinations. And countries are trying to isolate cases of the variant that South African studies have shown could potentially re-infect humans as well.

In March of last year, long before scientists became angry about variants, Shabir Madhi, a veteran vaccinologist at the Witwatersrand University, began to persuade vaccine manufacturers to conduct trials.

Dr. Realizing how long Africa often waits for life-saving vaccines as it did with swine flu vaccinations a decade ago, Madhi wanted to quickly examine how Covid-19 vaccines work on the continent, even with people with HIV no excuse for the world the delay in permits or deliveries. Different socio-economic and health conditions can alter the performance of vaccines.

“I’m sure I can get money,” he emailed the Oxford team on March 31 last year, adding that “it would be important to evaluate in relation to HIV.”

Oxford agreed, and the Bill and Melinda Gates Foundation contributed $ 7.3 million, cementing its role as the linchpin of efforts to steer vaccine trials to the global south.

Even so, the process had to contend with difficulties that larger studies with better resources in the US and Europe did not have. On the one hand, Dr. Madhi eliminate several test sites because they did not have sufficiently cold freezers or emergency power generators. This is necessary in a country where frequent power outages can put valuable doses at risk.

Even when the researchers locked down sites and relied on clinics with experience conducting HIV studies, the study was almost rolled back. The test results showed that almost half of the earliest volunteers were already infected with the virus at the time of vaccination, invalidating their results.

Updated

March 13, 2021, 6:24 p.m. ET

“We had a limited amount of funding and a limited number of vaccines,” said Dr. Cutland. “We were very concerned that the process had completely derailed.”

At another test site, all three pharmacists have signed Covid-19 and have withdrawn the only people who are allowed to prepare shots. Nurses in the study lost siblings and parents to the disease. The staff was so overwhelmed that the phones sometimes rang when vaccine managers called from abroad.

The magnitude of the pandemic in South Africa – 51,000 people have died and up to half the population may be infected – nearly overturned the process. But that was also part of what attracted vaccine makers: More cases mean faster results.

Dr. Madhi’s team weathered the storm, working 12-hour days and adding last-minute swabs to make sure the volunteers weren’t already infected. By May, he had asked Novavax, then a little-known American company with the support of the Trump administration, to conduct a lawsuit there too. Novavax agreed, and the Gates Foundation raised $ 15 million. However, the process was not registered until a few months later.

Novavax said the process took some time. However, the delay also reflected what scientists have called pressure on American-backed vaccine manufacturers to focus their efforts on the United States. Studies there are the best way to unlock coveted approvals from the Food and Drug Administration, the world’s gold standard drug agency.

And vaccine manufacturers tend to know their largest markets best.

“Companies have the greatest experience of clinical trials in parts of the world that represent their commercial markets,” said Dr. Feinberg.

For vaccine manufacturers who have made supplying the world a core part of their strategies, the trials have been a boon. Novavax showed that the effectiveness of the vaccine was only moderately weakened by the variant in South Africa. Johnson & Johnson, who also conducted a South African study, showed that their vaccine was protected from hospitalization and death there.

What you need to know about the vaccine rollout

“You have your fishing line in the water – and by the time we were there the virus developed,” said Dr. Gregory Glenn, President of Research and Development at Novavax. “This is invaluable data for us and the world.”

In a recent laboratory study, the Oxford-AstraZeneca vaccine protected hamsters exposed to the variant from disease, even when the animals’ immune responses were slightly weaker. The human study in South Africa was too small to be able to say definitively whether the vaccine prevents serious diseases. Finding that it offers minimal protection from milder cases was itself daunting, as the shot remains the backbone of the introduction of many poorer countries.

In South Africa, the results failed because of plans to give the Oxford vaccine to health workers. Despite the implementation of trials, the country was unable to use them for early purchase agreements and delayed deliveries. Only a fifth of 1 percent of the people there have been vaccinated, raising fears of another wave of deaths and further mutations.

If HIV research laid the groundwork for vaccine trials in South Africa, some scientists hope that an explosion in global studies on the pandemic will show drug companies that other countries have the infrastructure to conduct larger studies.

To this end, the Gates-supported Coalition for Epidemic Preparedness Innovations offers companies incentives to conduct further Covid-19 vaccine trials in poorer countries.

“People tend to go for what they know,” said Melanie Saville, the coalition’s director of vaccine research and development. “However, in low- and middle-income countries, capacity is increasing and we need to encourage developers to use it.”

Large numbers of South Africans volunteered for the trials. Most mornings, Dr. Anthonet Koen, who operated a location in Johannesburg for the Oxford and Novavax processes, opened their doors at 6 a.m. At this point, the participants had already been outside for two hours.

On December 11th, Dr. Koen that the pandemic was increasing: After weeks without a case, two people in the study tested positive. Then more and more every day. Health officials announced the discovery of the variant a week later. The random placement of the studies gave the scientists what they almost never had: an open-air laboratory where they could watch in real time how a vaccine and a variant stood in front of them.

Since the Oxford results were announced last month, volunteers have tried to comfort them, said Dr. Koen: “I get a lot of condolences and ‘I’m sorry’,” she said.

As long as this vaccine prevents and other serious diseases, the world can live with the virus even in cases of the variant, scientists said. However, the trial in South Africa underscored the need to eradicate the virus before it mutates further. Without them, scientists said, the world could have been blind to what was to come.

“We would assume that these variants are not the end of the story,” said Andrew Pollard, the Oxford scientist responsible for his experiments. “For the virus to survive, it must continue to mutate once the populations have good immunity to the current variants.”